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The method follows interactions accurately
The complex dissociation constants of p-aminobenzamidine (PABZM)
and pentamidine were evaluated. Similar results were obtained
compared to biochemical assay (see Table 1).
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Biochemical assays are commonly used as screening technology
in medicinal chemistry programs. They require a low amount of
protein, are high throughput and straightforward to establish.
This screening methodology is one of the most popular
approaches to screen fragments (i.e., small molecules that have
low affinities for the target and that will be grown into a larger
compound upon optimization). However, biochemical assays are
burdened with various interferences such as aggregators,
fluorescent compounds or impurities. Therefore, orthogonal
methods are needed to confirm fragment hits.[1]




Fig. 2: Screening results from affinity capillary electrophoresis (x value) in comparison 
with biochemical FXIIa assay (y value).
We developed and evaluated a partial-filling affinity capillary
electrophoresis methodology with factor XIIa (FXIIa) as target for
fragment counter-screen (Fig. 1). The method was applied to the
screening of a small focused library and the results were
compared to those obtained with the biochemical assay. The
origin of some discrepant results was also investigated.
The method counter-screened a fragment library
A library of 24 fragments was screened by the biochemical assay and by
the affinity capillary electrophoresis method (Fig. 2). A good correlation
was observed between the two methodologies. Major differences were
noticed with the compounds 1, 2, and 3. They exhibit a high ranking in
the biochemical assay but are under or near the threshold in affinity
capillary electrophoresis.
The method is unaffected by metallic contamination
To explain the discrepancy noticed with compounds 1, 2, and 3, we
suspected their contamination by divalent metallic cations. First, we
challenged the two methodologies with reference compounds
spiked with metallic impurity. Unlike biochemical assay, the affinity
capillary electrophoresis assay was unaffected by the metallic
contamination of the samples. Regarding compounds 1, 2, and 3,
the presence of zinc in the samples was identified by capillary
electrophoresis using pre-capillary CDTA complexation (Fig. 3).
Biochemical FXIIa assay is sensitive to the presence of low-level metallic impurity. Zinc
contamination led to three false positives, generating misleading structure-activity relationships.
Hence, cross-validation by orthogonal techniques is essential to avoid wasting time and
resources. Our study showed that affinity capillary electrophoresis can be powerful for fragment
counter-screening thanks to its separative character.
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Method PABZM Pentamidine
Biochemical assay 163.2 ± 0.5 12.4 ± 0.1
Affinity capillary electrophoresis 149 ± 14 6.3 ± 0.1
Table 1: Complex dissociation constants of reference compounds
Fig. 3: Electropherograms of compound 3 (in black) and compound 3 spiked with 
1.5 mM Zn2+ (in red). 
